| 摘要 |
<p>The present invention relates to an improved camptothecin composition for treating a patient having a disease associated with underised cell growth or proliferation, including for example cancer. More particularly, the present invention is directed to a composition comprising camptothecin or a camptothecin-related compound and a DNA polymerase sigma inhibitor.</p> |
